IR

  • HOME
  • IR
  • 2018 IR News

IR News 2018


Nov 14, 2018 News Sierra Oncology presented the result of preclinical study for SRA141 at EORTC-NCI-AACR Symposium
Sierra Oncology reported the result of preclinical study for SRA141(AS-141), a CDC7 inhibitor being developed by Sierra under license from Carna Biosciences, at EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics.

Dr. Kohichiro Yoshino, President and CEO at Carna said, “We are excited that SRA141 showed the safer and superior anti-tumor profile than competitor's compounds, which suggests beneficial effects of SAR141 in clinical trials."
For more information, please visit https://www.sierraoncology.com/.
Nov 09, 2018 Financials "Financial Results FY2018 Q3 " in IR Library. PDF
Nov 09, 2018 Financials "Consolidated Financial Results for the Third Quarter of the Year Ending December 31, 2018" in IR Library. PDF
Nov 09, 2018 Release "Successful Completion of IND filing with FDA for SRA141" in IR Library. PDF
Oct 02, 2018 News Dr. Masaaki Sawa, CSO of Carna Biosciences, presented at the 16th Annual Discovery on Target in Boston
Dr. Masaaki Sawa, CSO of Carna Biosciences, presented our work on the discovery of AS-871, currently being developed to treat Rheumatoid Arthritis, at the 16th Annual Discovery on Target held in Boston on September 25-28. Dr. Sawa presented Carna’s unique approach to develop a highly selective BTK inhibitor, and received many questions and favorable comments from the participants.
Sep 20, 2018 Release "Research Paper on Discovery of Carna Novel BTK inhibitor, Published in Journal of Medicinal Chemistry" in IR Library. PDF
Sep 18, 2018 News Updated Research Report by Shared Research Inc.
Aug 10, 2018 Release "Sierra Oncology reports on the progress of SRA141" in IR Library. PDF
Aug 07, 2018 Financials "Financial Results FY2018 Q2" in IR Library. PDF
Aug 06, 2018 Financials "Consolidated Financial Results for the Second Quarter of the Year Ending December 31, 2018" in IR Library. PDF
Jun 14, 2018 News Updated Research Report by Shared Research Inc.
May 14, 2018 News Updated Research Report by Shared Research Inc.
May 11, 2018 Financials "Consolidated Financial Results for the First Quarter of the Year Ending December 31, 2018 " in IR Library. PDF
May 11, 2018 Financials Financial Results FY2018 Q1 PDF
May 08, 2018 Release "Evotec and Carna Biosciences Collaborate on INDiGO Platform" in IR Library.
May 07, 2018 Release "National Cancer Center and Carna Biosciences Announce Research Collaboration for new drug discovery targets" in IR Library. PDF
Apr 13, 2018 News Dr. Masaaki Sawa, Ph.D., CSO of CarnaBio, will present our work on the discovery of AS-871, currently being developed to treat Rheumatoid Arthritis, at the 16th Annual Discovery on Target (DOT) conference in Boston.
Date: September 25-28
Location: Boston, MA, USA
Title: Discovery of AS-871, a Selective and Non-Covalent BTK Inhibitor for the Treatment of Rheumatoid Arthritis.
URL: http://www.discoveryontarget.com/kinase-inhibitor-discovery/
Apr 09, 2018 News Updated Research Report by Shared Research Inc.
Apr 04, 2018 News Updated Pipeline and Partnering pages at Carna Drug Dicovery website.
Mar 27, 2018 Release "Carna Biosciences and Sumitomo Dainippon Pharma Sign Agreement on Joint Research, Development, and Commercialization of Kinase Inhibitors" in IR Library. PDF
Feb 13, 2018 Financials "Financial Results FY2017" in IR Library. PDF
Feb 09, 2018 News Updated pipeline.
Feb 09, 2018 Financials "Consolidated Financial Results for the Year Ended December 31, 2017" in IR Library. PDF
Page Top